Sep 2026· International Journal of Biomathematics· 0 citations
TL;DR
A new module for Lung and Colon Cancer detection from histopathological images named Harmonic Tanimoto constrained Huber loss (HTCH-Loss) with Correlative Capsule Scale Attention Network (CCSAN) framework is designed to tackle problems of variability within classes and inconsistent staining.
Abstract
Lung and colon cancers are among the most common cancer in all over the world, affecting both males and females. Early detection is crucial to reduce mortality. However, the difficulty of diagnosis often depends on the histopathologist’s experience. Histopathological images offer detailed tissue-level information, but manual analysis is time-consuming and labor-intensive. Variability within classes and inconsistent staining make diagnosis challenging. Recently, Deep Learning (DL) has attained popularity for improving medical image interpretation. Therefore, a new module for Lung and Colon Cancer detection from histopathological images named Harmonic Tanimoto constrained Huber loss (HTCH-Loss) with Correlative Capsule Scale Attention Network (CCSAN) framework is designed to tackle these problems. The histopathological images based on minority and majority classes are initially fed to the Dual-Generative Adversarial Network (GAN) mechanism for realistic synthetic image generation. Here, both real and synthetic images are obtained. After that, the histopathological image is integrated to form a new dataset. Then, blood cell segmentation is done by Lightweight Feature Attention Network (LFANet). Thereafter, Deep Ensemble Feature Extraction (Deep EFE) is performed. Afterwards, lung cancer detection is done using CCSAN with HTCH-Loss. Moreover, CCSAN is modified by using HTCH-Loss, which is the integration of Tanimoto loss, constrained focal loss, and Huber loss, with the harmonic concept. Simultaneously, a similar process is followed for colon cancer detection. Experimental results demonstrate that the proposed CCSAN with HTCH-Loss attains superior accuracy values of 95.237% for lung cancer detection and 96.669% for colon cancer detection.
A brain tumor is a life-threatening disease that carries a high mortality burden. It can be treated if detected in the early stages. Manual analysis by a radiologist using Magnetic Resonance Imaging (MRI) is effective but slow and subject to inter-observer variability. In order to automate it, various deep learning mod...
J. Sahoo, Surendra Kumar Nanda, Ganapati Panda et al.· Bioengineering· 0 citations
Early and accurate analysis of breast cancer is critical for improving patient outcomes. Ultrasound imaging is widely used for breast tumor screening due to its safety, accessibility, and low cost. We propose DGTN (Diffused Graph-Transformer Network), a lightweight, end-to-end deep learning model that jointly performs...
Asfand Ali, B. Raza, Kiran Zahra et al.· Bioengineering· 0 citations
The proposed MLHNet-Lung framework for image-level classification of adenocarcinoma, large cell carcinoma, normal, and squamous cell carcinoma CT slices demonstrates the value of jointly modeling complementary intermediate and high-level CT representations; however, patient-level multicenter validation and clinically v...
Fareeha Hanif, A. Ahmed, Ali Raza· Frontiers in Medicine· 0 citations
The results suggest that MSTF-Net is a robust framework for automated lung cancer identification and can assist radiologists to make clinical decisions.
Pramod Kumar· Journal of Intelligent Decis...· 0 citations
The proposed system offers an efficient, accurate, and interpretable decision-support tool that has the potential to assist pathologists in clinical breast cancer diagnosis while promoting trust in AIdriven healthcare applications.
V. Parvathi· International Journal of Eng...· 0 citations
Breast cancer is the most common cancer and the second leading cause of cancer-related death among women worldwide. For accurate diagnosis, pathologists use immunohistochemical (IHC) staining for biomarkers such as human epidermal growth factor receptor 2 (HER2) as an auxiliary test, in addition to hematoxylin and eosi...
Dong-Bum Kim, Jong-Ha Lee· Biosensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.